Transmolecular-butyrophilin3A PAg-signalling in PAg mediated activation of Vγ9Vδ2T cells

被引：0
|
作者：
Karunakaran, M. M. [1 ]
Starick, L. [1 ]
Noehren, A. [1 ]
Laender, N. [1 ]
Herrmann, T. [1 ]
机构：
[1] Univ Wurzburg, Inst Virol & Immunobiol, Med, Wurzburg, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 007
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [21] Development of V γ 9V δ 2T cell based chemo-immunotherapy in bladder cancer
    Shimizu, Teruki
    Tomogane, Mako
    Miyashita, Masatsugu
    Sano, Yusuke
    Shimizu, Daiki
    Ukimura, Osamu
    Ashihara, Eishi
    CANCER SCIENCE, 2018, 109 : 433 - 433
  • [22] In vitro expansion of Vγ9Vδ2 T cells for immunotherapy
    Peters, Christian
    Kouakanou, Leonce
    Oberg, Hans-Heinrich
    Wesch, Daniela
    Kabelitz, Dieter
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - CELLULAR METHODS, PT A, 2020, 631 : 223 - 237
  • [23] Prevention of Vγ9Vδ2 T cell activation by a Vγ9Vδ2 TCR nanobody (vol 198, pg 308, 2017)
    de Bruin, R. C. G.
    Stam, A. G. M.
    Vangone, A.
    Henegouwen, P. M. P. van Bergen En
    Verheul, H. M. W.
    Sebestyen, Z.
    Kuball, J.
    Bonvin, A. M. J. J.
    de Gruijl, T. D.
    van der Vliet, H. J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (09): : 3759 - 3759
  • [24] Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2T Cells
    Dunne, Margaret R.
    Mangan, Bozgana A.
    Madrigal-Estebas, Laura
    Doherty, Derek G.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [25] Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
    Gu, Siyi
    Sachleben, Joseph R.
    Boughter, Christopher T.
    Nawrocka, Wioletta I.
    Borowska, Marta T.
    Tarrasch, Jeffrey T.
    Skiniotis, Georgios
    Roux, Benoit
    Adams, Erin J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (35) : E7311 - E7320
  • [26] Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing
    Wu, Zeguang
    Lamao, Qiezhong
    Gu, Meichao
    Jin, Xuanxuan
    Liu, Ying
    Tian, Feng
    Yu, Ying
    Yuan, Pengfei
    Gao, Shuaixin
    Fulford, Thomas S.
    Uldrich, Adam P.
    Wong, Catherine C. L.
    Wei, Wensheng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (04) : 362 - 373
  • [27] 一种经济简单的方法扩增Vγ9Vδ2T细胞
    曹伟
    崔莲仙
    何维
    中华微生物学和免疫学杂志, 2007, (01)
  • [28] Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells
    Qu Cui
    Hironobu Shibata
    Asuka Oda
    Hiroe Amou
    Ayako Nakano
    Kenichiro Yata
    Masahiro Hiasa
    Keiichiro Watanabe
    Shingen Nakamura
    Hirokazu Miki
    Takeshi Harada
    Shiro Fujii
    Kumiko Kagawa
    Kyoko Takeuchi
    Shuji Ozaki
    Toshio Matsumoto
    Masahiro Abe
    International Journal of Hematology, 2011, 94 : 63 - 70
  • [29] Vγ9Vδ2 T cell response to colon carcinoma cells
    Corvaisier, M
    Moreau-Aubry, A
    Diez, E
    Bennouna, J
    Mosnier, JF
    Scotet, E
    Bonneville, M
    Jotereau, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (08): : 5481 - 5488
  • [30] Human Vγ9Vδ2 T cells: From signals to functions
    Nedellec, Steven
    Bonneville, Marc
    Scotet, Emmanuel
    SEMINARS IN IMMUNOLOGY, 2010, 22 (04) : 199 - 206
12345